Immunizations

References

Citations

1. National Advisory Committee on Immunization (NACI) (2007). Thimerosal: Updated statement. Canada Communicable Disease Report, 33(ACS-6): 1–13. Also available online: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07pdf/acs33-06.pdf.

2. National Advisory Committee on Immunization (NACI) (2005). Updated recommendation on the use of thimerosal-containing vaccines in Canada. Canada Communicable Disease Report, 31(ACS-12): 1–4. Also available online: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/05vol31/asc-dcc-12/index.html.

3. Demicheli V, et al. (2007). Vaccines for measles, mumps and rubella in children. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

4. National Advisory Committee on Immunization (NACI) (2006). Recommended immunization. In Canadian Immunization Guide, 7th ed. Ottawa: Public Health Agency of Canada. Also available online: http://publications.gc.ca.

5. Strauss B, Bigham DM (2001). Does measles-mumps-rubella (MMR) vaccination cause inflammatory bowel disease and autism? Canada Communicable Disease Report, 27(8): 65–72. Available online: http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/ccdr-rmtc/01vol27/dr2708e.html.

6. Pneumococcal vaccine (Prevnar) for otitis media (2003). Medical Letter on Drugs and Therapeutics, 45 (W1153B): 27–28.

7. National Advisory Committee on Immunization (NACI) (2007). Meningococcal C conjugate vaccination recommendations for infants. Canada Communicable Disease Report, 33(ACS-11): 1–12.

8. National Advisory Committee on Immunization (NACI) (2006). Menningococcal vaccine. In Canadian Immunization Guide, 7th ed., pp. 237–250. Ottawa: Public Health Agency of Canada.

9. National Advisory Committee on Immunization (NACI) (2007). Statement on influenza vaccination for the 2007–2008 season. Canada Communicable Disease Report, 33(ACS-7): 1–24. Also available online: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07vol33/acs-07/index_e.html

10. Canadian Paediatric Society (2004). Recommendation for the use of influenza vaccine for children. Paediatrics and Child Health, 9(7): 283–284. Also available online: http://www.cps.ca/english/statements/ID/ID04-01.htm.

11. Troisi CL, et al. (1997). Immunization of seronegative infants with hepatitis A vaccine (HARRIX; SKB): A comparative study of two dosing schedules. Vaccine, 15(15): 1613–1617.

12. Dagan R, et al. (2000). Immunization against hepatitis A in the first year of life: Priming despite the presence of maternal antibody. Pediatric Infection Disease Journal, 19(11): 1045–1052.

13. National Advisory Committee on Immunization (NACI) (2006). Canadian Immunization Guide, 7th ed., pp. 1–372. Ottawa: Public Health Agency of Canada. Also available online: http://publications.gc.ca.

14. National Advisory Committee on Immunization (2007). Statement on human papillomavirus vaccine. Canada Communicable Disease Report, 33(ACS-2): 1–32.

15. National Advisory Committee on Immunization (NACI) (2006). Hepatitis B vaccine. In Canadian Immunization Guide, 7th ed., pp. 189–204. Ottawa: Public Health Agency of Canada.

16. National Advisory Committee on Immunization (NACI) (2006). Hepatitis vaccines combined. In Canadian Immunization Guide, 7th ed., pp. 205–208. Ottawa: Public Health Agency of Canada.

17. National Advisory Committee on Immunization (NACI) (2006). Statement on influenza vaccination for the 2006–2007 season. Canada Communicable Disease Report, 32(ACS-7): 1–28. Also available online: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/06vol32/acs-07/index.html.

18. National Advisory Committee on Immunization (NACI) (2006). Recommended immunization: Immunization in pregnancy and breast-feeding. In Canadian Immunization Guide, 7th ed., pp. 107–112. Ottawa: Public Health Agency of Canada.

19. National Advisory Committee on Immunization (NACI) (2006). Pertussis vaccine. In Canadian Immunization Guide, 7th ed., pp. 257–266. Ottawa: Public Health Agency of Canada. Also available online: http://publications.gc.ca.

20. Naus M, et al. (2005). Interval between administration of vaccines against diphtheria, tetanus, and pertussis. Canada Communicable Disease Report, 31(ACS-9): 1–6. Available online: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/05vol31/acs-dcc-8-9/9_e.html.

21. Ryan ET, Kain KC (2000). Health advice and immunizations for travelers. New England Journal of Medicine, 342(23): 1716–1725.

22. Breman JG, Henderson DA (2002). Diagnosis and management of smallpox. New England Journal of Medicine, 346(17): 1300–1308.

23. Public Health Agency of Canada (2005). Emergency preparedness: Smallpox. Available online: http://www.phac-aspc.gc.ca/ep-mu/smallpox_e.html.

Other Works Consulted

• American Academy of Family Physicians, American Academy of Pediatrics, Advisory Committee on Immunization Practices, and U.S. Public Health Service (2000). Joint Statement Concerning Removal of Thimerosal From Vaccines. Available online: http://www.cdc.gov/nip/vacsafe/concerns/thimerosal/joint_statement_00.htm.

• American Academy of Pediatrics (2007). Hepatitis A vaccine recommendations. Pediatrics, 120(1): 189–199. Also available online: http://aappolicy.aappublications.org/cgi/reprint/pediatrics;120/1/189.pdf.

• Atkinson W, et al., eds. (2007). Epidemiology and Prevention of Vaccine-Preventable Diseases, 10th ed. (The Pink Book). Washington, DC: Public Health Foundation. Also available online: http://www.cdc.gov/vaccines/pubs/pinkbook/default.htm. [Errata and updates available online: http://www.cdc.gov/vaccines/pubs/pinkbook/pink-errata.htm.]

• Centers for Disease Control and Prevention (1998). Measles, mumps, and rubella—Vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 47(RR-8): 1–59. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr4708.pdf.

• Centers for Disease Control and Prevention (2005). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR, 54(RR-16): 1–23. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a1.htm.

• Centers for Disease Control and Prevention (2005). Meningococcal conjugate vaccine: ACIP recommends meningococcal for adolescents and college freshmen. Available online: http://www.cdc.gov/niP/vaccine/mening/mcv4/mcv4_acip.htm.

• Centers for Disease Control and Prevention (2006). General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 55(RR-15): 1–48. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5515.pdf.

• Centers for Disease Control and Prevention (2006). Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 55(RR-3): 1–44. Also available online: http://www.cdc.gov/mmwr/PDF/RR/RR5503.pdf.

• Centers for Disease Control and Prevention (2006). Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee, for Use of Tdap Among Health-Care Personnel. MMWR, 55(RR-17): 1–37. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5517.pdf.

• Centers for Disease Control and Prevention (2006). Shingles vaccine: What you need to know. Vaccine Information Statement. Department of Health and Human Services, National Immunization Program (9/11/06). Available online: http://www.cdc.gov/nip/publications/VIS/vis-shingles.pdf.

• Centers for Disease Control and Prevention (2007). Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 56(RR-4): 1–48. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5604.pdf.

• Committee on Infectious Disease, American Academy of Pediatrics (1999). Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization. Pediatrics, 104(6): 1404–1406.

• Committee on Infectious Diseases, American Academy of Pediatrics (2000). Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics, 106(2): 362–366.

• Dear KB G, et al. (2006). Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

• Pneumococcal vaccine (Prevnar) for otitis media (2003). Medical Letter on Drugs and Therapeutics, 45 (W1153B): 27–28.

• Reis EC, et al. (1998). Taking the sting out of shots: Control of vaccination-associated pain and adverse reactions. Pediatric Annals, 27(6): 375–386.

• Weller PF (2005). Health advice for international travelers. In DC Dale, DD Federman, eds., ACP Medicine, Clinical Essentials, chap. 7. New York: WebMD.

Go to previous section	Go to top of page	Go to next section
Author:	Douglas Dana	Last Updated: May 23, 2008
Medical Review:	Anne C. Poinier, MD - Internal Medicine Thomas Emmett Francoeur, MDCM, CSPQ, FRCPC - Pediatrics
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.